Skip to main content
. 2020 Sep 30;2020:2483435. doi: 10.1155/2020/2483435

Figure 3.

Figure 3

Effects of GLP-1RA treatment on circulating Fetuin-B and insulin sensitivity in PCOS women. (a) M values in PCOS subjects during the EHC after GLP-1RA treatment. (b) Average GIR in PCOS subjects during the EHC at pre- and posttreatment. (c) Serum Fetuin-B levels in PCOS subjects before and after GLP-1RA treatment. (d) Blood glucose 572 levels in PCOS subjects during an OGTT at pre- and posttreatment. (e) AUCg in PCOS subjects during an OGTT at pre- and posttreatment. (f) Insulin levels in PCOS subjects during an OGTT at pre- and posttreatment. (g) AUCi in PCOS subjects during an OGTT at pre- and posttreatment. Data are means ± SEM.∗p < 0.05 or ∗∗p < 0.01 vs. baseline.